Tendinitis Treatment Market to Undertake Strapping Growth by 2023

The Americas & Europe Tendinitis Treatment Market report explores the Top Key Players in-depth analysis as
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the global Beauty Devices Market over the forecast period.
The Americas & Europe Tendinitis Treatment Market is expected to reach USD 13,099.0 million by 2023 from USD 7,525.3 million as of 2016 and is expected to grow at a CAGR of 7.2% during the forecast period.
Tendinitis is the inflammation of the tendon, thick cords that attache the muscles to the bone. The inflammation occurs as a result of sudden injury to the tendon, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter's syndrome or lupus. In case of patients with gout, the uric acid crystals appear in the tendon sheath leading to friction. Tendinitis is found to be prevalent among athletes and is one of the common sport injuries in sport players, especially tennis, golf and others. Various pharmacological and non-pharmacological treatments are available for the treatment of tendinitis. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) constitute the preliminary treatment options. Other treatments including physical therapy, rest, and occupational therapy. Surgery is the last resort for tendinitis, and is only recommended in case of severe damage to the tendon that cannot be treated using pharmacological treatment options.

The market for tendinitis treatment is expected to grow at an exponential rate owing to increasing prevalence of sports injuries, rising geriatric population, increasing prevalence of patients suffering from diabetes and rheumatoid arthritis. Side effects of the treatment i.e. use of NSAIDs leading to stomach upset, and Gastrointestinal (GI) bleeding.

Americas & Europe Tendinitis Treatment Market Key Findings:
• By type, Achilles tendinitis acquired the largest market share in 2016.
• By treatment, diagnosis accounted for the largest market share in 2016 and is valued at USD 1200 million.
• By end user, hospitals & clinics accounted for the largest market share of 41.8% in the Americas & Europe tendinitis market, in 2016.
Key Players in the Americas & Europe Tendinitis Treatment Market:
Some of the key players in this market are Abbott (U.S.), Pfizer (U.S.), AstraZeneca (U.K), Bayer (Germany), Merck & Co. Inc. (Germany), GlaxoSmithKline plc (U.S.), Teva Pharmaceutical Industries (Israel), Boehringer Ingelheim Pharmaceuticals, Inc. (Germany), and others.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/5227 .
Americas & Europe Tendinitis Treatment Segments:
The Americas & Europe Tendinitis Treatment Market is segmented on the basis of type, treatment, and end user.
On the basis of type, the market is segmented into Achilles tendinitis, supraspinatus tendinitis, tennis or golfer's elbow, De Quervain's tenosynovitis, and others.
On the basis of treatment, the market is segmented into diagnosis, therapy, shock wave therapy or surgery, medical devices, devices, and others.
Diagnosis is further segmented into physical examination, imaging tests, ultrasound, Magnetic Resonance Imaging (MRI) Scans, and others.
Therapy is further segmented into non-pharmacological and pharmacological therapy. Non-pharmacological therapy includes rest therapy, heat & cold therapy, occupational therapy, physical therapy, and others. Pharmacological therapy includes OTC drugs or pain relievers, corticosteroids injections, platelet-rich plasma (PRP), and others.
Medical devices segment is further segmented mechanical band, support tape, pre-cut strips, continuous rolls, and others.
On the basis of end user, the market is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Regional Analysis of the Americas & Europe Tendinitis Treatment Market:
America is the largest Tendinitis Treatment Market owing to an increasing demand for new treatment options for tendinitis, and rising prevalence of sport injuries and disease such as arthritis. Furthermore, increasing number of sport injuries also influence the growth of the market. Sports medicine, is now gaining roots in the developing, and the developed regions of America. In America, North America captures the largest share in the tendinitis treatment market.
According to the Center for Disease Control and Prevention, an estimated 78 million i.e. 26% of the U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Additionally, the prevalence of tendinitis among athletes is found to be increasing from last few years in the U.S.
In Europe, the prevalence of diabetes and rheumatoid arthritis is on the rise. Furthermore, availability of funds for research and development activities in medical devices enhance the demand for technologically advanced devices for the diagnosis for tendinitis. Diabetes is one to the major risk factors for tendinitis. According to the report published by World Health Organization (WHO) in 2015, over 60 million people were suffering from diabetes in the European Region. Furthermore, lifestyle changes and lack of physical activity also influence the growth of this market in Europe. In Europe, Western European captures the largest share with German in leading position.
Major Table of Contents:
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Americas & Europe Tendinitis Market, By Type
7 Americas & Europe Tendinitis Market, By Treatment
8 Americas & Europe Tendinitis Market, By End User
9 Americas & Europe Tendinitis Market, By Region
10 Company Landscape
11 Company Profiles
12 Conclusion
… T.O.C. Continued
Get Discount @ https://www.marketresearchfuture.com/check-discount/5227 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

MRFR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Years of research into diverse fields of work has ingrained within us, a proficiency so distinguished that our industry-specific specialists identify with your business ideas and feel the pulse of your challenges and opportunities. This enables us for providing assistance, through our consulting and strategic consulting services, in informed managerial decision making. In order to stay updated with technology and work process of the industries, WantStats Research and Media often conducts industrial visits for its research analysts. Relevant inputs from various established market participants, help our clients make significant contribution in respective markets are a huge motivation for all of us to endlessly furnish quality. We depend greatly on profound insights into complex realms of our study.

Pune, India

This release was published on openPR.